Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis

Srujana Rayalam1, Mary Anne Della-Fera, Clifton A Baile

  • 1Department of Animal and Dairy Science, University of Georgia, Athens, GA, USA.

Insights

Resveratrol, a natural compound, reduces fat cell formation and boosts bone cell development. Combining it with other compounds may offer new therapies for obesity and osteoporosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Gerontology

Background:

  • Resveratrol, a phytoalexin, is known for its effects on sirtuins.
  • Its anti-cancer properties are well-studied, but its anti-adipogenic and osteogenic effects are gaining interest.
  • Resveratrol supplementation mimics caloric restriction, influencing lipid metabolism.

Purpose of the Study:

  • To investigate the effects of resveratrol on adipogenesis and osteogenesis.
  • To explore the inverse relationship between adipocytes and osteoblasts in bone marrow, particularly in aging populations.
  • To evaluate the synergistic effects of resveratrol with other phytochemicals.

Main Methods:

  • Studied resveratrol's effects on molecular targets in adipocytes and osteoblasts.
  • Investigated the impact of resveratrol combined with genistein and quercetin on adipogenesis in murine and human adipocytes.
  • Analyzed an in vivo study using phytochemicals including resveratrol and vitamin D in a postmenopausal rat model.

Main Results:

  • Resveratrol decreases adipocyte number and size while increasing osteogenesis.
  • Resveratrol, genistein, and quercetin synergistically reduced adipogenesis.
  • Phytochemical combinations prevented weight gain and bone loss in a rat model.

Conclusions:

  • Resveratrol influences mesenchymal stem cell differentiation, favoring osteogenesis over adipogenesis.
  • Combinations of resveratrol with other phytochemicals show promise for treating obesity and osteoporosis.
  • Further research into these combinations may lead to novel therapeutic strategies.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...